NIH: Universal Flu Vaccine, FluMos-v2, designed to target 6 flu strains begins clinical trials

NewsDesk@bactiman63 Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health's Clinical Center in Bethesda, Maryland. The trial is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, and will evaluate the investigational vaccine for safety and [...]

The post NIH: Universal Flu Vaccine, FluMos-v2, designed to target 6 flu strains begins clinical trials appeared first on Outbreak News Today.